Insider filing · CYTK
John T Henderson
Director
profile →
Cytokinetics, Incorporated
CYTK · Healthcare · 120 filings in 24 months
ticker →
John T Henderson sold $559K of Cytokinetics (CYTK)
Executed Dec 2 2025, disclosed Dec 2 2025, the same day.
Value, as filed
$559K
8,750 sh × $63.90
Executed
Dec 2 2025
the trade date, as filed
Disclosed
Dec 2 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JHJohn T Henderson (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $1.5M of CYTK (20,000 sh × $75.97, as filed), executed May 5.
The name
CYTKHealthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John T Henderson in CYTK
CYTKSALE
Cytokinetics, Incorporated
$1.5M20,000 sh × $75.97
Exec May 5
Filed May 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $123K
3,190 sh × $38.66
Exec Apr 15 2025
Filed Apr 16 2025 · 5:30 PM ET